When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 18 Mar 2025
Last updated: 21 May 2024

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • nocturnal onset (idiopathic cramp)
  • gastrocnemius muscle involvement, with or without foot involvement (idiopathic cramp)
  • duration <10 minutes (idiopathic cramp)
  • unilateral (idiopathic cramp)
  • precipitation by both trivial movements and forceful contractions (idiopathic cramp)
  • visible or palpable muscular knotting
  • good response to passive/active stretching (idiopathic cramp)
  • normal neurological examination (idiopathic cramp)
  • normal general physical examination (idiopathic cramp)
  • other local muscle involvement (neuromuscular disease cramp)
  • widespread muscle cramps (lower motor neuron disease)
  • duration >10 minutes (organic cause)
  • abnormal neurological examination (organic cause)
  • abnormal musculoskeletal examination (organic cause)

Other diagnostic factors

  • signs of a chronic medical condition (organic cause)

Risk factors

  • pregnancy
  • strenuous exercise
  • haemodialysis
  • cirrhosis
  • use of imatinib
  • use of beta-blockers with intrinsic sympathomimetic activity
  • age >60 years
  • female sex
  • family history of cramp
  • use of statins
  • use of other agents that may cause muscle cramps
  • hypoglycaemia in patients with diabetes mellitus
  • chronic diseases
  • home parenteral nutrition

Diagnostic investigations

Investigations to consider

  • serum or urine hCG
  • fasting serum metabolic panel
  • thyroid-stimulating hormone (TSH)
  • HbA1c
  • serum liver function tests
  • prothrombin time (PT) and INR
  • serum myoglobin and urinalysis
  • serum creatine kinase (CK)-MM
  • serum alpha-tocopherol (vitamin E)
  • serum zinc
  • electromyogram
  • nerve conduction studies
  • serum aldolase
  • muscle biopsy
  • genetic studies

Treatment algorithm

Contributors

Authors

Michael Rubin, MD, FRCP(C)

Professor of Clinical Neurology

Weill Cornell Medical College

Attending Neurologist

Director, Neuromuscular Service and EMG Laboratory

New York Presbyterian Hospital

New York

NY

Disclosures

MR states that he has no competing interests.

Acknowledgements

Dr Michael Rubin would like to gratefully acknowledge Dr Justin Mhoon and Dr David R.P. Guay, previous contributors to this topic. JM declares that he has no competing interests. DRPG is an author of a reference cited in this topic.

Peer reviewers

Timothy M. Miller, MD, PhD

Assistant Professor of Neurology

Department of Neurology

Washington University School of Medicine

St. Louis

MO

Disclosures

TMM is an author of a reference cited in this topic.

Sami Khella, MD

Physician

Department of Neurology

Penn Presbyterian Medical Center

University of Pennsylvania Health System

Philadelphia

PA

Disclosures

SK declares that he has no competing interests.

Felicity Goodyear-Smith, MB CHB, DipObs, MGP, FRNZCGP, MFFLM, RCP

Professor and Goodfellow Postgraduate Chair

Department of General Practice & Primary Health Care

University of Auckland

Auckland

New Zealand

Disclosures

FG-S declares that she has no competing interests.

Use of this content is subject to our disclaimer